Winlevi release date?

When is Winlevi (clascoterone) released, and what is its launch date?

Winlevi (clascoterone) is an FDA-approved topical treatment for acne. Its approval date was June 11, 2020, which is the closest “release” milestone available in public records tied to market availability [1].

Was Winlevi released immediately after approval, and when did patients start seeing it?

The FDA approval date (June 11, 2020) marks when Winlevi cleared the regulatory step needed to be marketed in the U.S. Public sources typically treat this approval date as the key reference point for “release,” since a precise nationwide “first pharmacy shelf date” is not consistently reported.

Is there a “UK/EU release date” or only a U.S. launch date?

“Release date” depends on the country/region and the time of local regulatory authorization. If you tell me whether you mean U.S., UK, or EU, I can narrow to the correct approval/launch timing for that market.

Patent/exclusivity context: could launch timing affect availability or competitors?

Winlevi’s market timeline can also be tied to patent and exclusivity landscape as other products seek approval later. DrugPatentWatch.com tracks such IP details and can be useful when looking at availability over time [2].

Sources

1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213798s000lbl.pdf
   
2. https://www.drugpatentwatch.com/